Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8433075 | Cancer Epidemiology | 2016 | 7 Pages |
Abstract
The lack of a similar plateau in mortality may be because the second most prevalent stage of diagnosis in recent years was stage III, indicating diagnosis at advanced symptomatic stages. Cervical cancer incidence is expected to continue to decrease if screening programs are strengthened and human papillomavirus vaccines are widely utilized. As Bulgaria has shared cervical cancer trends with other Eastern European countries in the past, it may be beneficial to develop future prevention interventions based on a regional, rather than a country-specific level.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kaeli K. M.A. M.P.H, Gleb Ph.D. D.Sc., Amr S. M.D. Ph.D., Zdravka M.D. Ph.D.,